BSI response to the MHRA approval of the use of Moderna's bivalent COVID-19 vaccine
The BSI response to the JCVI's advice on which COVID vaccines should form part of the upcoming booster programme.
A coalition of immune-related medical research charities announce ten innovative autoimmunity research projects to increase our understanding of autoimmunity and how to treat it.
The BSI has issued a statement in response to a pre-print reporting on new human challenge study using SARS-CoV-2.
A new study has found that patients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the general population. This paper was published in the journal Clinical & Experimental Immunology.
The BSI's response to the joint report from the House of Commons Health and Social Care and Science and Technology Select Committees examining the UK's initial response to the Covid pandemic.
Our response to the annual report on childhood vaccination coverage statistics for England in 2020-21.
BSI response to a new report from the Association of the British Pharmaceutical Industry on clinical research in the UK
British Society for Immunology statement in response to a recommendation from the UK's chief medical officers that healthy children aged 12 to 15 should be offered one dose of a COVID-19 vaccine.
The British Society for Immunology statement in response to the Government's decision to offer a third dose of a COVID-19 vaccine to priority groups this autumn and winter.
BSI response to first published findings from the OCTAVE trial on immune responses generated by COVID vaccines in people with impaired immune systems
Urgent strategic investment in veterinary vaccinology is crucial to secure global health, wealth and security, according to a new report published today by the British Society for Immunology and the International Veterinary Vaccinology Network.
Pioneering partnership between medical research charities and charitable trust brings significant new investment to confront the UK’s high prevalence of autoimmune conditions.
Bowel Research UK has joined Connect Immune Research, an initiative designed to bring about a critical change in the way autoimmune conditions are researched. The BSI is a supporting partner of this initiative, along members JDRF, the MS Society, Versus Arthritis, Alopecia UK, the Psoriasis and Psoriatic Arthritis Alliance and Coeliac UK.
Coeliac UK has joined Connect Immune Research, an initiative designed to bring about a critical change in the way autoimmune conditions are researched. The BSI is a supporting partner of this initiative, along members JDRF, the MS Society, Versus Arthritis, Alopecia UK and the Psoriasis and Psoriatic Arthritis Alliance.